Literature DB >> 24522639

Pancreatic pathology in type 1 diabetes mellitus.

Sarah J Richardson1, Noel G Morgan, Alan K Foulis.   

Abstract

Type 1 diabetes is a multifactorial disease resulting from a complex interplay between host genetics, the immune system and the environment, that culminates in the destruction of insulin-producing beta cells. The incidence of type 1 diabetes is increasing at an alarming rate, especially in children under the age of 5 (Gepts in Diabetes 14(10):619-613, 1965; Foulis et al. in Lancet 29(5):267-274, 1986; Gamble, Taylor and Cumming in British Medical Journal 4(5887):260-262 1973). Genetic predisposition, although clearly important, cannot explain this rise, and so, it has been proposed that changes in the 'environment' and/or changes in 'how we respond to our environment' must contribute to this rising incidence. In order to gain an improved understanding of the factors influencing the disease process, it is important, firstly, to focus on the organ at the centre of the illness-the pancreas. This review summarises our knowledge of the pathology of the endocrine pancreas in human type 1 diabetes and, in particular, explores the progression of this understanding over the past 25 years.

Entities:  

Mesh:

Year:  2014        PMID: 24522639     DOI: 10.1007/s12022-014-9297-8

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  69 in total

1.  Enterovirus replication in valvular tissue from patients with chronic rheumatic heart disease.

Authors:  Y Li; Z Pan; Y Ji; T Peng; L C Archard; H Zhang
Journal:  Eur Heart J       Date:  2002-04       Impact factor: 29.983

2.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

3.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

4.  Expression of coxsackievirus B3 capsid proteins in Escherichia coli and generation of virus-specific antisera.

Authors:  S Werner; W M Klump; H Schönke; P H Hofschneider; R Kandolf
Journal:  DNA       Date:  1988-06

5.  Immunohistochemical analysis of the relationship between islet cell proliferation and the production of the enteroviral capsid protein, VP1, in the islets of patients with recent-onset type 1 diabetes.

Authors:  A Willcox; S J Richardson; A J Bone; A K Foulis; N G Morgan
Journal:  Diabetologia       Date:  2011-05-20       Impact factor: 10.122

Review 6.  A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence.

Authors:  A Imagawa; T Hanafusa; J Miyagawa; Y Matsuzawa
Journal:  Ann Med       Date:  2000-11       Impact factor: 4.709

7.  Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach.

Authors:  J K S Chia; A Y Chia
Journal:  J Clin Pathol       Date:  2007-09-13       Impact factor: 3.411

Review 8.  C. L. Oakley lecture (1987). The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus.

Authors:  A K Foulis
Journal:  J Pathol       Date:  1987-07       Impact factor: 7.996

9.  Screening for insulitis in adult autoantibody-positive organ donors.

Authors:  Peter In't Veld; Dirk Lievens; Joeri De Grijse; Zhidong Ling; Bart Van der Auwera; Miriam Pipeleers-Marichal; Frans Gorus; Daniel Pipeleers
Journal:  Diabetes       Date:  2007-06-11       Impact factor: 9.461

10.  Enterovirus RNA in blood is linked to the development of type 1 diabetes.

Authors:  Sami Oikarinen; Mika Martiskainen; Sisko Tauriainen; Heini Huhtala; Jorma Ilonen; Riitta Veijola; Olli Simell; Mikael Knip; Heikki Hyöty
Journal:  Diabetes       Date:  2010-10-13       Impact factor: 9.461

View more
  29 in total

1.  Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity.

Authors:  Magloire Pandoua Nekoua; Antoine Bertin; Famara Sane; Enagnon Kazali Alidjinou; Delphine Lobert; Jacques Trauet; Christine Hober; Ilka Engelmann; Kabirou Moutairou; Akadiri Yessoufou; Didier Hober
Journal:  Cell Mol Life Sci       Date:  2019-06-06       Impact factor: 9.261

Review 2.  The impact of anti-inflammatory cytokines on the pancreatic β-cell.

Authors:  M A Russell; N G Morgan
Journal:  Islets       Date:  2014       Impact factor: 2.694

Review 3.  Combination immunotherapies for type 1 diabetes mellitus.

Authors:  Paolo Pozzilli; Ernesto Maddaloni; Raffaella Buzzetti
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

4.  Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes.

Authors:  Federica Vecchio; Nicola Lo Buono; Angela Stabilini; Laura Nigi; Matthew J Dufort; Susan Geyer; Paola Maria Rancoita; Federica Cugnata; Alessandra Mandelli; Andrea Valle; Pia Leete; Francesca Mancarella; Peter S Linsley; Lars Krogvold; Kevan C Herold; Helena Elding Larsson; Sarah J Richardson; Noel G Morgan; Knut Dahl-Jørgensen; Guido Sebastiani; Francesco Dotta; Emanuele Bosi; Manuela Battaglia
Journal:  JCI Insight       Date:  2018-09-20

5.  Interferon-α mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes.

Authors:  Laura Marroqui; Reinaldo S Dos Santos; Anne Op de Beeck; Alexandra Coomans de Brachène; Lorella Marselli; Piero Marchetti; Decio L Eizirik
Journal:  Diabetologia       Date:  2017-01-06       Impact factor: 10.122

Review 6.  β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity.

Authors:  Teresa Mezza; Francesca Cinti; Chiara Maria Assunta Cefalo; Alfredo Pontecorvi; Rohit N Kulkarni; Andrea Giaccari
Journal:  Diabetes       Date:  2019-06       Impact factor: 9.461

Review 7.  Potential role of type I interferon in the pathogenic process leading to type 1 diabetes.

Authors:  Natasha Qaisar; Agata Jurczyk; Jennifer P Wang
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-04       Impact factor: 3.243

8.  Evaluation of RT-PCR and immunohistochemistry as tools for detection of enterovirus in the human pancreas and islets of Langerhans.

Authors:  Oskar Skog; Sofie Ingvast; Olle Korsgren
Journal:  J Clin Virol       Date:  2014-07-30       Impact factor: 3.168

9.  Isolation of human monoclonal autoantibodies derived from pancreatic lymph node and peripheral blood B cells of islet autoantibody-positive patients.

Authors:  Mara Catani; Denise Walther; Michael R Christie; Kerry A McLaughlin; Ezio Bonifacio; Anne Eugster
Journal:  Diabetologia       Date:  2016-02       Impact factor: 10.122

Review 10.  Strategies for clinical trials in type 1 diabetes.

Authors:  Mario R Ehlers
Journal:  J Autoimmun       Date:  2016-04-05       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.